In this special sponsored episode from Eli Lilly and Company, I am joined by Dr. Lee James, senior vice president of oncology medical affairs at Lilly, to discuss the importance of lung cancer screening, early detection, and advances in biomarker testing. We explore how low-dose CT screening can reduce mortality, yet remains underused, and why comprehensive genomic profiling is essential to understanding the molecular drivers of non-small cell lung cancer and guiding targeted treatment decisions. Tune in to learn how expanding access to screening and precision medicine is helping create new hope for people affected by lung cancer.

VISIT SPONSOR → https://www.lilly.com/conditions/cancer/lung-cancer

SUBSCRIBE TO THE PODCAST → https://www.kevinmd.com/podcast

RECOMMENDED BY KEVINMD → https://www.kevinmd.com/recommended

Patient advocate Richard A. Lawhern, PhD, discusses the article "U.S. opioid policy history: How politics replaced science in pain care." Richard argues that for decades, public policy on pain treatment has been driven by sociopolitical factors rather than medical science. He traces the history from the "business corruption" phase of pill mills to the current "political phase" launched by the 2016 CDC guidelines. The conversation highlights how anti-opioid zealotry and legal fears have forced physicians to abandon effective pain care, leaving patients to suffer or turn to illicit markets. Richard also critiques the rising reliance on buprenorphine, suggesting it is popular not because of superior efficacy for pain, but because it offers a legal "safe harbor" for clinicians. Discover why Richard believes the confusion between physical dependence and addiction is driving a public health failure.

Partner with me on the KevinMD platform. With over three million monthly readers and half a million social media followers, I give you direct access to the doctors and patients who matter most. Whether you need a sponsored article, email campaign, video interview, or a spot right here on the podcast, I offer the trusted space your brand deserves to be heard. Let's work together to tell your story.

PARTNER WITH KEVINMD → https://kevinmd.com/influencer

SUBSCRIBE TO THE PODCAST → https://www.kevinmd.com/podcast

RECOMMENDED BY KEVINMD → https://www.kevinmd.com/recommended

Medical student Umayr R. Shaikh discusses his article "The impact of CDC's new childhood immunization guidance." Umayr argues that recent CDC changes, moving vaccines like flu, Hep B, and meningococcal from universal recommendation to shared decision making, risk normalizing preventable illness. He highlights how his medical training now focuses on diagnosing diseases that should be rare footnotes. The conversation explores the danger of treating public health as an individual choice, warning that this shift will disproportionately harm vulnerable populations and widen health inequities. Discover why rebuilding trust in evidence based prevention is critical to avoiding a future of predictable outbreaks.

Partner with me on the KevinMD platform. With over three million monthly readers and half a million social media followers, I give you direct access to the doctors and patients who matter most. Whether you need a sponsored article, email campaign, video interview, or a spot right here on the podcast, I offer the trusted space your brand deserves to be heard. Let's work together to tell your story.

PARTNER WITH KEVINMD → https://kevinmd.com/influencer

SUBSCRIBE TO THE PODCAST → https://www.kevinmd.com/podcast

RECOMMENDED BY KEVINMD → https://www.kevinmd.com/recommended